Total Ideas
3
Bullish Ideas
2 (67%)
Bearish Ideas
0 (0%)
Recent Activity
1

"Oh, it's a surprise. It's a surprise because we know President Trump's signing an executive order um changing the drug classification for cannabis to move cannabis into a less restrictive federal category. So, I'm looking at Tillray and Canopy, Tillray, T LR Y, and Canopy CGC. But both shares are edging lower by 1.3% and 3 and a half% respectively, which was priced in."
The speaker highlights a regulatory catalyst as President Trump's executive order stands to shift cannabis into a category reserved for drugs with accepted medical uses. Tillray is mentioned specifically alongside Canopy, with current market moves already reflecting the news.

"Imperial Brands is another top performer in Europe. It is on track to meet its full targets thanks to growth in both tobacco and new generation products, and it recently announced a new buyback of 1.45 billion pounds. The new CEO, who started on October 1st, now faces the challenge of executing a five-year strategy to 2030, which focuses on continuing cigarette growth while scaling new generation products and creating a more efficient organization."
The commentary centers on Imperial Brands surpassing expectations with robust performance in both traditional tobacco and new generation products. The fresh share buyback and the new CEO's five-year strategic plan are seen as catalysts to drive further operational improvements and growth, adding a positive nuance to the stock's outlook.

"Tillray Brands, ticker TLR Y, was up about 61% here at the close, pretty much finishing the day at its highs of the session. President Trump posted a video on social media yesterday that touts medical benefits of hemp derived CBD for seniors."
Tillray Brands saw an explosive 61% surge, catalyzed by a presidential video highlighting the medical benefits of hemp-derived CBD, suggesting increased investor interest driven by political endorsements and media attention.
Sentiment